India Globalization Capital, Inc.(Other OTC/NBB : IGC)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -1.94% | 88.65 | 1.3% | $796.69m | |
| AMGN | Amgen Inc. | -0.76% | 185.50 | 1.2% | $630.51m | |
| GILD | Gilead Sciences, Inc. | -2.14% | 65.55 | 0.9% | $497.34m | |
| BIIB | Biogen Inc. | -4.17% | 321.17 | 1.3% | $426.56m | |
| ILMN | Illumina, Inc. | -1.77% | 296.88 | 3.5% | $314.34m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.92% | 418.62 | 2.6% | $301.49m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -2.55% | 183.06 | 1.9% | $262.15m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.76% | 127.55 | 2.0% | $232.43m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.87% | 136.54 | 15.4% | $150.79m | |
| A | Agilent Technologies, Inc. | -0.83% | 77.91 | 1.6% | $143.97m | |
| EXAS | Exact Sciences Corporation | -0.42% | 83.28 | 25.3% | $128.91m | |
| INCY | Incyte Corporation | -0.49% | 83.33 | 2.5% | $114.75m | |
| ARRY | Array BioPharma Inc. | -1.99% | 22.71 | 8.2% | $107.63m | |
| EXEL | Exelixis, Inc. | -0.09% | 21.22 | 6.4% | $83.96m | |
| NBIX | Neurocrine Biosciences, Inc. | -2.58% | 77.31 | 5.1% | $78.49m |
Company Profile
India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications such as Alzheimer's disease, Parkinson's disease, and pain. It operates through Legacy Infrastructure and Alternative Therapies segments. The Legacy Infrastructure segment involves in the trading of infrastructure commodities like steel and iron ore; and rental of heavy equipment. The Alternative Therapies segment focuses on the development and commercialization of cannabinoid-based combination therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Bethesda, MD.